EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Blood Pressure Management in Intracerebral Haemorrhage: when, how much, and for how long?

Chloe A Mutimer, Nawaf Yassi, Teddy Y Wu

Current Neurology and Neuroscience Reports · 2024-07 · 24 (7) · 181-189

DOI: 10.1007/s11910-024-01341-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Neurology and Neuroscience Reports, online erschienen am 23.05.2024. Verfasst von Chloe A Mutimer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, 3050, Australia. ch…. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Blood Pressure. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose of Review When compared to ischaemic stroke, there have been limited advances in acute management of intracerebral haemorrhage. Blood pressure control in the acute period is an intervention commonly implemented and recommended in guidelines, as elevated systolic blood pressure is common and associated with haematoma expansion, poor functional outcomes, and mortality. This review addresses the uncertainty around the optimal blood pressure intervention, specifically timing and length of intervention, intensity of blood pressure reduction and agent used. Recent Findings Recent pivotal trials have shown that acute blood pressure intervention, to a systolic target of 140mmHg, does appear to be beneficial in ICH, particularly when bundled with other therapies such as neurosurgery in selected cases, access to critical care units, blood glucose control, temperature management and reversal of coagulopathy. Summary Systolic blood pressure should be lowered acutely in intracerebral haemorrhage to a target of approximately 140mmHg, and that this intervention is generally safe in the ICH population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageBlood PressureHumansAntihypertensive AgentsHypertensionDisease Management

Stichwörter der Autor:innen

Antihypertensive AgentsHypertensionIntracerebral HaemorrhagePatient care Bundles

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, 3050, Australia. chloe.mutimer@mh.org.au.
  • Department of Medicine and Neurology, Melbourne Brain Centre at The Royal Melbourne Hospital, University of Melbourne, Parkville, 3050, Australia.
  • Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, 3052, Australia.
  • Department of Neurology, Christchurch Hospital, Christchurch, New Zealand.
  • Department of Medicine, University of Otago, Christchurch, New Zealand.

Förderung

  • University of Melbourne

Zitieren

APA

Mutimer, C. A., Yassi, N., & Wu, T. Y. (2024). Blood Pressure Management in Intracerebral Haemorrhage: when, how much, and for how long?. Current Neurology and Neuroscience Reports, 24(7), 181-189. https://doi.org/10.1007/s11910-024-01341-2

Vancouver

Mutimer CA, Yassi N, Wu TY. Blood Pressure Management in Intracerebral Haemorrhage: when, how much, and for how long?. Current Neurology and Neuroscience Reports. 2024;24(7):181-189. doi:10.1007/s11910-024-01341-2

BibTeX
@article{Mutimer2024,
  author = {Mutimer, Chloe A and Yassi, Nawaf and Wu, Teddy Y},
  title = {Blood Pressure Management in Intracerebral Haemorrhage: when, how much, and for how long?},
  journal = {Current Neurology and Neuroscience Reports},
  year = {2024},
  volume = {24},
  number = {7},
  pages = {181--189},
  doi = {10.1007/s11910-024-01341-2}
}
Kostenlos starten →